Recent Quotes (30 days)

You have no recent quotes
chg | %

GlaxoSmithKline plc news

   Watch this stock
Showing stories 1 - 10 of about 167   

Articles published

GSK 1,541.50 -12.50 (-0.80%)
price chart
GlaxoSmithKline plc And SkyePharma PLC: A Match Made In Heaven?
GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) is a great stock for any portfolio. Indeed, the company has all the best qualities you could ask for - a high dividend yield, attractive valuation healthy balance sheet, dominant market position and a reliable ...
The Benefits Of Investing In GlaxoSmithKline plc
With economic growth in developing regions and thus investment in domestic healthcare continuing to power higher, demand for GlaxoSmithKline's suite of market-leading products is likely to keep on rising. Indeed, the pharmaceutical-play saw emerging ...
It's Official! Vodafone Group plc, GlaxoSmithKline plc & Imperial Tobacco ...
Every year, the top City analysts produce a chart outlining the best dividend yields on offer in the developed markets consumer goods sector.
Why GlaxoSmithKline plc And Shire plc Are Dividend And Growth Buys
GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP) would be my pick of the pharmaceutical companies to invest in at the moment.
3 Reasons Why GlaxoSmithKline plc And AstraZeneca plc Are Worth Buying ...
US) did not come off last year, both it and sector peer GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) could prove to be realistic bid targets moving forward.
GlaxoSmithKline plc (GSK) Continues To Be One Of The Most Attractive Pharma ...  InvestCorrectly
GlaxoSmithKline plc To Go Ex-Dividend on February 18th (GSK)  The Legacy
Which Is The Better Pick For Your Portfolio: GlaxoSmithKline plc Or ...
If you're struggling to choose between GlaxoSmithKline (LSE: GSK) and AstraZeneca (LSE: AZN), you're not alone.
3 Reasons I Believe GlaxoSmithKline plc Is One Step Ahead Of AstraZeneca plc
Today, it's a different picture: much of AstraZeneca's likely future recovery has now been priced into the stock, and the Anglo-Swedish firm's shares trade on a more demanding rating of 16.1 times 2015 forecast earnings.
How Safe Are GlaxoSmithKline plc And AstraZeneca plc's Dividends?
GlaxoSmithKline has actually kept its dividend growing, but back in 2010 it wasn't covered by earnings. And though 2011 got things back on track, falling earnings for the next three years took cover down to just 1.2 times -- and there's cover of only 1 ...
190 Million Reasons To Buy GlaxoSmithKline plc
Like the rest of the pharmaceuticals sector, GlaxoSmithKline (LSE: GSK) (NYSE: GSK.US) has been taking increasingly-aggressive measures to hammer its product pipeline back into shape and counter the relentless trend of patent losses across its ...
GlaxoSmithKline plc Receives A+ Credit Rating from Morningstar (GSK)
GlaxoSmithKline plc logo GlaxoSmithKline plc (NYSE:GSK) has been given an �A+� credit rating by analysts at Morningstar.
GlaxoSmithKline plc (ADR) To Close Asset Swap Deal With Novartis AG (ADR ...  Bidness ETC
GlaxoSmithKline plc announces changes to its Board  The FINANCIAL